業績

英文論文

  • Risk factors for mediastinal lymph node metastasis and lung metastasis in papillary thyroid carcinoma patients: who benefits from preoperative computed tomography?

    Omi Y, Yanagida J, Yoshida Y, Horiuchi K, Okamoto T.
    Endocr J. 2024 Jan 19.

  • Diagnosis and management of adrenal incidentaloma: use of clinical judgment and evidence in dialog with the patient.

    Yoshida Y, Horiuchi K, Otsuki M, Okamoto T.
    Surg Today. 2023 Dec 13.

  • Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma.

    Horiuchi K, Fujimoto M, Hidenori K, Yoshida Y, Noguchi E, Omi Y, Okamoto T.
    World J Surg. 2023 Oct;47(10):2464-2473.

  • Patient-Reported Outcomes in Patients with Low-Risk Papillary Thyroid Carcinoma: Cross-Sectional Study to Compare Active Surveillance and Immediate Surgery.

    Kazusaka H, Sugitani I, Toda K, Sen M, Saito M, Nagaoka R, Yoshida Y.
    World J Surg. 2023 May;47(5):1190-1198.

  • Papillary thyroid microcarcinoma with multiple pulmonary metastases following lung cancer surgery: a case report.

    Kamio H, Onizuka H, Yoshida Y, Omi Y, Isaka T, Nagashima Y, Horiuchi K, Okamoto T.
    Surg Case Rep. 2022 Dec 8;8(1):218.

  • Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study.

    Omi Y, Haniu K, Kamio H, Fujimoto M, Yoshida Y, Horiuchi K, Okamoto T.
    World J Surg Oncol. 2022;20(1):394.

  • Genetic analysis of pheochromocytoma and paraganglioma complicating cyanotic congenital heart disease.

    Ogasawara T, Fujii Y, Kakiuchi N, Shiozawa Y, Sakamoto R, Ogawa Y, Ootani K, Ito E, Tanaka T, Watanabe K, Yoshida Y, Kimura N, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S.
    J Clin Endocrinol Metab. 2022;107(9):2545-2555.

  • Fatigue and quality of life among thyroid cancer survivors without persistent or recurrent disease.

    Maki Y, Horiuchi K, Okamoto T.
    Endocr Connect. 2022;11(2):e210506.

  • Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes.

    Dong W, Horiuchi K, Noguchi E, Okamoto T.
    Head Neck. 2022;44(7):1623-1630.

  • Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.

    Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H, Teshima M, Horiguchi K, Yoshida Y, Kanai T, Hirokawa M, Hames KY, Tabei I, Miyauchi A.
    Thyroid. 2021;31(2):183-192.

  • A case of Turner's syndrome with Graves' disease and primary hyperparathyroidism.

    Nagaki S, Tachikawa E, Kodama H, Obara T, Osawa M, Nagata S.
    SAGE Open Med Case Rep. 2021;9:1-4.

  • Breast metastasis from medullary thyroid carcinoma: a report of a case.

    Omi Y, Kamio H, Yoshida Y, Masui K, Yamamoto T, Nagashima Y, Okamoto T.
    Surg Case Rep. 2021;7(1):188.

  • JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.

    Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
    J Gastroenterol. 2021;56(11):1033-1044.

  • Acute decompensated heart failure in a patient with primary aldosteronism successfully treated with an adrenalectomy: A case report.

    Imamura Y, Suzuki A, Nomoto M, Takano M, Sawa S, Hoki R, Kikuchi N, Yoshida Y, Uto K, Niinami H, Hagiwara N.
    J Cardiol Cases. 2021;25(3):140-143.

  • Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.

    Horiguchi K and Yoshida Y, Iwaku K, Emoto N, Kasahara T, Sato J, Shimura H, Shindo H, Suzuki S, Nagano H, Furuya F, Makita N, Matsumoto F, Manaka K, Mitsutake N, Miyakawa M, Yokoya S, Sugitani I.
    Endocr J. 2021;68(7):763-780.

  • Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery.

    Yoshida Y, Horiuchi K, Okamoto T.
    Thyroid. 2020;30(5):681-687.

  • Parathyroid carcinoma in a 13-year-old girl with a long-term survival.

    Omi Y, Yamamoto T, Nagashima Y, Abe K, Karasawa K, Tanaka Y, Okamoto T.
    Surg Case Rep. 2020;6(1):145

  • Radioactive iodine treatment of papillary thyroid carcinoma in Japan.

    Okamoto T, Omi Y, Yoshida Y, Horiuchi K, Abe K.
    Gland Surg. 2020;9(5):1698-1707

  • Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.

    Larsen LV, Mirebeau-Prunier D, Imai T, Alvarez-Escola C, Hasse-Lazar K, Censi S, Castroneves LA, Sakurai A, Kihara M, Horiuchi K, Barbu VD, Borson-Chazot F, Gimenez-Roqueplo AP, Pigny P, Pinson S, Wohllk N, Eng C, Aydogan BI, Saranath D, Dvorakova S, Castinetti F, Patocs A, Bergant D, Links TP, Peczkowska M, Hoff AO, Mian C, Dwight T, Jarzab B, Neumann HPH, Robledo M, Uchino S, Barlier A, Godballe C, Mathiesen JS.
    Endocr Connect. 2020;9(6):489-497.

  • Effects of surgery on the patient-reported outcomes of primary hyperparathyroidism patients with mild hypercalcemia without classic symptoms: a systematic review of the literature.

    Horiuchi K, Yoshida Y, Okamoto T.
    Surg Today. 2020;50(7):650-656.

  • Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.

    Abe K, Ishizaki U, Ono T, Horiuchi K, Kanaya K, Sakai S, Okamoto T.
    Ann Nucl Med. 2020;34(2):144-151.

  • Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up.

    Dong W, Horiuchi K, Tokumitsu H, Sakamoto A, Noguchi E, Ueda Y, Okamoto T.
    Thyroid. 2019;29(6):802-808.

  • Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.

    Omi Y, Horiuchi K, Haniu K, Tokura M, Nagai E, Isozaki O, Nagashima Y, Okamoto T.
    Endocr J. 2018;65(2):245-252.

  • Impact of "Tailored" Parathyroidectomy for Treatment of Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1.

    Horiuchi K, Sakurai M, Haniu K, Nagai E, Tokumitsu H, Yoshida Y, Omi Y, Sakamoto A, Okamoto T.
    World J Surg. 2018;42(6):1772-1778.

  • SAFETY AND TOLERABILITY OF VANDETANIB IN JAPANESE PATIENTS WITH MEDULLARY THYROID CANCER: A PHASE I/II OPEN-LABEL STUDY.

    Uchino K, Komoda M, Tomomatsu J, Okamoto T, Horiuchi K, Tsuji A, Ito Y, Todo T, Rito K, Takahashi S.
    Endocr Pract. 2017;23(2):149-156.

  • Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions.

    Sakurai A, Imai T, Kikumori T, Horiuchi K, Okamoto T, Uchino S, Kosugi S, Suzuki S, Suyama K, Yamazaki M, Sato A; MEN Consortium of Japan.
    Clin Endocrinol (Oxf). 2013;78(2):248-254.

  • Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine. neoplasia type 1: the experience at a single institution.

    Horiuchi K, Okamoto T, Iihara M, Tsukada T.
    Surg Today. 2013;43(8):894-899.

  • Thoracoscopic removal of mediastinal parathyroid lesions: selection of surgical approach and pitfalls of preoperative and intraoperative localization.

    Iihara M, Suzuki R, Kawamata A, Horiuchi K, Okamoto T.
    World J Surg. 2012;36(6):1327-1334.

  • A large deletion in the succinate dehydrogenase B gene (SDHB) in a Japanese patient with abdominal paraganglioma and concomitant metastasis.

    Hitomi Kodama, Masatoshi Iihara, Sumiko Nissato, Kazumasa Isobe, Yasushi Kawakami, Takahiro Okamoto, Kazuhiro Takekoshi.
    Endocr J. 2010;57(4):351-356.

  • Parathyroid carcinoma: etiology, diagnosis, and treatment.

    Okamoto T, Iihara M, Obara T, Tsukada T.
    World J Surg. 2009;33(11):2343-2354.

  • Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy.

    Kaoru Nomura, Hironari Kimura, Satoru Shimizu, Hitomi Kodama, Takahiro Okamoto, Takao Obara, Kazue Takano.
    J Clin Endocrinol Metab. 2009;94(8):2850-2856.

  • Bone mineral density before and after surgical cure of Cushing's syndrome due to adrenocortical adenoma: prospective study.

    Kawamata A, Iihara M, Okamoto T, Obara T.
    World J Surg. 2008;32(5):890-896.

  • Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia.

    Kanji Sato, Yoko Omi, Hitomi Kodama, Takao Obara, Kazuko Yamazaki, Emiko Yamada, Toshiro Seki, Kazue Takano, Tsuyoshi Shiga, Hiroshi Kasanuki.
    Intern Med. 2008;47(8):757-762.

  • Preoperative localization of pancreatic insulinoma by super selective arterial stimulation with venous sampling.

    Morita S, Machida H, Kuwatsuru R, Saito N, Suzuki K, Iihara M, Obara T, Mitsuhashi N.
    Abdom Imaging. 2007;32(1):126-128.

  • Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis.

    Iihara M, Okamoto T, Suzuki R, Kawamata A, Nishikawa T, Kobayashi M, Obara T.
    Surgery. 2007;142(6):936-943.

  • Water-clear cell parathyroid adenoma causing primary hyperparathyroidism in a patient with neurofibromatosis type 1: report of a case.

    Hitomi Kodama, Masatoshi Iihara, Takahiro Okamoto, Takao Obara.
    Surg Today. 2007;37(10):884-887.

  • Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.

    Okamoto T, Yamazaki K, Kanbe M, Kodama H, Omi Y, Kawamata A, Suzuki R, Igari Y, Tanaka R, Iihara M, Ito Y, Sawada T, Nishikawa T, Maki M, Kusakabe K, Mitsuhashi N, Obara T.
    Breast Cancer. 2005;12(3):203-210.

  • Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.

    Nomura K, Saito H, Aiba M, Iihara M, Obara T, Takano K.
    Endocr J. 2003;50(2):155-162.

  • Adrenal-preserving laparoscopic surgery in selected patients with bilateral adrenal tumors.

    Masatoshi Iihara, Rumi Suzuki, Akiko Kawamata, Yoko Omi, Hitomi Kodama, Yuka Igari, Kiyomi Yamazaki, Takao Obara.
    Surgery. 2003;134(6):1066-1072.

  • Adult-type ganglioneuroblastoma in the adrenal gland treated by a laparoscopic resection: report of a case

    Koike K, Iihara M, Kanbe M, Omi Y, Aiba M, Obara T.
    Surg Today. 2003;33(10):785-790.

  • Adrenal-preserving laparoscopic surgery in selected patients with bilateral adrenal tumors.

    Iihara M, Suzuki R, Kawamata A, Omi Y, Kodama H, Igari Y, Yamazaki K, Obara T.
    Surgery. 2003;134(6):1066-1072.

  • Recent advances in minimally invasive pancreatic surgery.

    Iihara M, Obara T.
    Asian J Surg. 2003;26(2):86-91.

  • Minimally invasive endocrine surgery: laparoscopic resection of insulinomas.

    Iihara M, Obara T.
    Biomed Pharmacother. 2002;56(Sup 1):227-230.

  • Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.

    K Sato, T Obara, K Yamazaki, M Kanbe, K Nakajima, A Yamada, T Yanagisawa, Y Kato, T Nishikawa, K Takano.
    J Clin Endocrinol Metab. 2001;86(11):5564-5571.

  • Laparoscopic ultrasonography for resection of insulinomas.

    Iihara M, Kanbe M, Okamoto T, Ito Y, Obara T.
    Surgery. 2001;130(6):1086-1091.

  • Management of hyperthyroidism due to Graves' and nodular diseases.

    Okamoto T, Iihara M, Obara T.
    World J Surg. 2000;24(8):957-961.

  • Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.

    K Sato, K Yamazaki, H Zhu, M Kanbe, M Iihara, Y Wada, R Tanaka, T Okamoto, Y Ito, T Obara.
    Surgery. 2000;127(3):337-341.

  • A novel splicing mutation (894-9 G --> A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1.

    M Kishi, T Tsukada, S Shimizu, K Hosono, T Ohkubo, T Kosuge, K Sugano, M Kanbe, T Obara, K Yamaguchi.
    Cancer Lett. 1999;142(1):105-110.

  • Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma.

    Y Ito 1, T Obara, T Okamoto, M Kanbe, R Tanaka, M Iihara, J Okamoto, K Yamazaki, K Jibiki.
    World J Surg. 1998;22(7):684-688.

  • A large germline deletion of the MEN1 gene in a family with multiple endocrine neoplasia type 1.

    M Kishi, T Tsukada, S Shimizu, H Futami, Y Ito, M Kanbe, T Obara, K Yamaguchi.
    Jpn J Cancer Res. 1998;89(1):1-5.

  • Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma.

    Ito Y, Obara T, Okamoto T, Kanbe M, Tanaka R, Iihara M, Okamoto J, Yamazaki K, Jibiki K.
    World J Surg. 1998;22(7):684-688.

  • Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan.

    Egawa S, Futami H, Takasaki K, Iihara M, Okamoto T, Kanbe M, Ohi T, Saio Y, Miyauchi A, Takiyama Y, Koga M, Miyanaga K, Inoue K, Mitsuyama S, Nomura Y, Takei H, Mugiya S, Ishida O, Zeze F, Shakutsui S, Inoue H, Oya H, Yoshimura A, Ishizuka S, Yamaguchi K, et al.
    Jpn J Clin Oncol. 1998;28(10):590-596.

  • Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.

    T Yamashita, M Lihara, J Okamoto, M Kanbe, Y Ito, M Kawakami, S Egawa, K Yamaguchi, T Obara.
    Jpn J Clin Oncol. 1997;27(1):42-45.

  • Measuring serum thyroglobulin in patients with follicular thyroid nodule: its diagnostic implications.

    T Okamoto, M Kanbe, M Iihara, K Yamazaki, J Okamoto, T Yamashita, Y Ito, M Kawakami, T Obara.
    Endocr J. 1997;44(1):187-193.

  • Germline mutations of the MEN1 gene in Japanese kindred with multiple endocrine neoplasia type 1.

    S Shimizu, T Tsukada, H Futami, K Ui, T Kameya, M Kawanaka, S Uchiyama, A Aoki, H Yasuda, S Kawano, Y Ito, M Kanbe, T Obara, K Yamaguchi.
    Jpn J Cancer Res. 1997;88(11):1029-1032.

  • Measuring serum thyroglobulin in patients with follicular thyroid nodule: its diagnostic implications.

    Okamoto T, Kanbe M, Iihara M, Yamazaki K, Okamoto J, Yamashita T, Ito Y, Kawakami M, Obara T.
    Endocr J. 1997;44(1):187-193.

  • Functioning parathyroid carcinoma: clinicopathologic features and rational treatment.

    Obara T, Okamoto T, Kanbe M, Iihara M.
    Semin Surg Oncol. 1997;13(2):134-141.

  • A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.

    M Iihara, T Yamashita, T Okamoto, M Kanbe, K Yamazaki, S Egawa, K Yamaguchi, T Obara.
    Jpn J Clin Oncol. 1997;27(3):128-134.

  • Pheochromocytomas: tendency to degenerate and cause paroxysmal hypertension.

    Y Ito, T Obara, T Yamashita, M Kanbe, M Iihara.
    World J Surg. 1996;20(7):923-926.

  • Bilateral adrenalectomy with autotransplantation of adrenocortical tissue or unilateral adrenalectomy: treatment options for pheochromocytomas in multiple endocrine neoplasia type 2A.

    T Okamoto, T Obara, Y Ito, T Yamashita, M Kanbe, M Iihara, K Hirose, K Yamazaki.
    Endocr J. 1996;43(2):169-175.

  • Pheochromocytomas: tendency to degenerate and cause paroxysmal hypertension.

    Ito Y, Obara T, Yamashita T, Kanbe M, Iihara M.
    World J Surg. 1996;20(7):923-926.

  • Decision Making Using Postoperative CEA and CA 15-3 for Detection of Breast Cancer Recurrence.

    T Okamoto, T Obara, M Izuo, Y Ito, T Yamashita, R Tanaka, M Kanbe, K Hirose.
    Breast Cancer. 1995;2(2):127-131.

  • Surgical strategy for pheochromocytoma: emphasis on the pledge of flank extraperitoneal approach in selected patients.

    T Obara, M Kanbe, T Okamoto, Y Ito, T Yamashita, K Ito, K Hirose, K Yamazaki, J Hagihara, K Kusakabe, et al.
    Surgery. 1995;118(6):1083-1089.